A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer

13Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: The CCCTC-binding factor (CTCF), known as a versatile transcription factor and chromatin insulator and to be involved in X inactivation, has also been suggested to be a tumour suppressor on 16q. We investigated 153 patients with familial non-BRCA1/BRCA2 breast cancer for germline mutations in the CTCF gene. Methods: Mutation screening of CTCF was performed by denaturing high-performance liquid chromatography followed by cycle sequencing. Results: We found two sequence variants, 240GA in the 5' untranslated region and 1455CT (S388S) in exon 4, in five familial breast cancer cases. Three of these five cases had both variants. Cases and controls showed the same prevalence for the two variants, which were found in linkage disequilibrium in most cases and controls. Conclusion: The present study suggests that germline mutations in CTCF are not important as a risk factor for breast cancer.

Cite

CITATION STYLE

APA

Zhou, X. L., Werelius, B., & Lindblom, A. (2004). A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer. Breast Cancer Research, 6(3). https://doi.org/10.1186/bcr774

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free